Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • IQVIA

    Tag: iqvia

    You Searched For "IQVIA"
    Cipla gets 12 USFDA observations for Goa facility

    Cipla gets 12 USFDA observations for Goa facility

    Medical Dialogues Bureau30 Sept 2019 3:15 PM IST
    "The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
    Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules

    Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules

    Farhat Nasim25 Jun 2019 11:54 AM IST
    The approved product, Oseltamivir Phosphate capsule is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Capsules of Hoffman-La...
    Shilpa Medicare gets USFDA nod for Irinotecan injection to treat cancer

    Shilpa Medicare gets USFDA nod for Irinotecan injection to treat cancer

    Farhat Nasim17 May 2019 1:45 PM IST
    Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added. NEW DELHI: Shilpa...
    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Farhat Nasim8 May 2019 10:15 AM IST
    Nitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood...
    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution

    Farhat Nasim2 May 2019 4:04 PM IST
    Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
    Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution

    Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution

    Farhat Nasim22 April 2019 11:55 AM IST
    Teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis while Tobramycin ophthalmic solution is a...
    Dr Reddy

    Dr Reddy's expands injectable portfolio with acquisition of 42 ANDAs in US

    Farhat Nasim15 April 2019 10:00 AM IST
    This transaction will help augment Dr Reddy's Labs injectables product portfolio in the U.S. market and globally.Hyderabad: Dr Reddy's Laboratories...
    Lupin launches generic Levothyroxine Sodium tablets

    Lupin launches generic Levothyroxine Sodium tablets

    Farhat Nasim22 March 2019 11:30 AM IST
    Lupin's Levothyroxine Sodium tablet is the generic version of AbbVie Inc's Synthroid tablets, it added. New Delhi: Drug firm Lupin Friday said it has...
    Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol

    Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol

    Farhat Nasim8 March 2019 9:45 AM IST
    Atorvastatin Calcium tablets are indicated to lower cholesterol in blood for adults and children over 10 years of age, Lupin said. It works by...
    Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets

    Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets

    Farhat Nasim6 March 2019 9:30 AM IST
    Imatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
    Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer

    Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer

    Farhat Nasim27 Feb 2019 9:30 AM IST
    The company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

    Farhat Nasim21 Feb 2019 9:45 AM IST
    Acetazolamide extended-release capsule is therapeutically equivalent to the reference listed drug, Diamox Sequels, 500 mg, of Teva Branded...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok